VAGI-CURE (MAXIMUM STRENGTH) (SCI International, Inc. DBA Continental Pharmaceuticals)
Welcome to the PulseAid listing for the VAGI-CURE (MAXIMUM STRENGTH) drug offered from SCI International, Inc. DBA Continental Pharmaceuticals. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | SCI International, Inc. DBA Continental Pharmaceuticals |
| NON-PROPRIETARY NAME: | BENZOCAINE, RESORCINOL |
| SUBSTANCE NAME: | BENZOCAINE; RESORCINOL |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
| START MARKETING DATE: | 2011-01-01 |
| END MARKETING DATE: | 0000-00-00 |
VAGI-CURE (MAXIMUM STRENGTH) HUMAN OTC DRUG Details:
| Item Description | VAGI-CURE (MAXIMUM STRENGTH) from SCI International, Inc. DBA Continental Pharmaceuticals |
| LABELER NAME: | SCI International, Inc. DBA Continental Pharmaceuticals |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200; 30(mg/g; mg/g) |
| START MARKETING DATE: | 2011-01-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 76466-010_00f75b55-0728-47b7-95fe-1a2c8cedc524 |
| PRODUCT NDC: | 76466-010 |
| APPLICATION NUMBER: | part348 |
Other BENZOCAINE; RESORCINOL Pharmaceutical Manufacturers / Labelers:
